Basic and clinical immunology

Journal of Allergy and Clinical Immunology

Volumn 116, Issue 2, 2005, Pages 411-418

  Chinen, Javier ^a   Shearer, William T ^b,c  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Complement; HIV; Immunodeficiency; Immunoregulation; Innate immunity

Indexed keywords

CORTICOSTEROID; DNA VACCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INACTIVATED VACCINE; INFLUENZA VACCINE; TOLL LIKE RECEPTOR;

ALGORITHM; ARTICLE; ASTHMA; BLOOD ANALYSIS; CELL INTERACTION; CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; GENE IDENTIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNOREGULATION; LUNG ALVEOLUS CELL; MEDICAL LITERATURE; MOLECULAR RECOGNITION; MONOCYTE; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE; X CHROMOSOME LINKAGE;

EID: 23244437270     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.05.010     Document Type: Review

References (54)

1. M. Wittmann, M. Alter, T. Stunkel, A. Kapp, and T. Werfel Cell-to-cell contact between activated CD4+ T lymphocytes and unprimed monocytes interferes with a TH1 response J Allergy Clin Immunol 114 2004 965 973
2. G. Lametschwandtner, T. Biedermann, C. Schwarzler, C. Gunther, J. Kund, and S. Fassl Sustained T-bet expression confers polarized human TH2 cells with TH1-like cytokine production and migratory capacities J Allergy Clin Immunol 113 2004 987 989
3. J.W. Upham, P.G. Holt, A. Taylor, C.A. Thornton, and S.L. Prescott HLA-DR expression on neonatal monocytes is associated with allergen-specific immune responses J Allergy Clin Immunol 114 2004 1202 1208
4. E. Goleva, A. Dunlap, and D.Y. Leung Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with beta2-adrenergic agonists J Allergy Clin Immunol 114 2004 183 191
5. E. Pace, R. Gagliardo, M. Melis, S. La Grutta, M. Ferraro, and L. Siena Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthma J Allergy Clin Immunol 114 2004 1216 1223
6. C.H. Hung, L.C. Chen, Z. Zhang, B. Chowdhury, W.L. Lee, and B. Plunkett Regulation of TH2 responses by the pulmonary Clara cell secretory 10-kd protein J Allergy Clin Immunol 114 2004 664 670
7. H.L. Spiegelberg, and E. Raz DNA-based approaches to the treatment of allergies Curr Opin Mol Ther 4 2002 64 71
8. B. Klostermann, I. Bellinghausen, I. Bottcher, A. Petersen, W.M. Becker, and J. Knop Modification of the human allergic immune response by allergen-DNA-transfected dendritic cells in vitro J Allergy Clin Immunol 113 2004 327 333
9. I. Ludwig-Portugall, E. Montermann, A. Kremer, A.B. Reske-Kunz, and S. Sudowe Prevention of long-term IgE antibody production by gene gun-mediated DNA vaccination J Allergy Clin Immunol 114 2004 951 957
10. S. Jilek, E. Walter, H.P. Merkle, and B. Corthesy Modulation of allergic responses in mice by using biodegradable poly(lactide-co-glycolide) microspheres J Allergy Clin Immunol 114 2004 943 950
11. D.T. O'Hagan, M. Singh, and J.B. Ulmer Microparticles for the delivery of DNA vaccines Immunol Rev 199 2004 191 200
12. L. Farkas, E.O. Kvale, F.E. Johansen, F.L. Jahnsen, and F. Lund-Johansen Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides J Allergy Clin Immunol 114 2004 436 443
13. O. Hajoui, R. Janani, M. Tulic, P. Joubert, T. Ronis, and Q. Hamid Synthesis of IL-13 by human B lymphocytes: regulation and role in IgE production J Allergy Clin Immunol 114 2004 657 663
14. M. Kawaguchi, F. Kokubu, M. Odaka, S. Watanabe, S. Suzuki, and K. Ieki Induction of granulocyte-macrophage colony-stimulating factor by a new cytokine, ML-1 (IL-17F), via Raf I-MEK-ERK pathway J Allergy Clin Immunol 114 2004 444 450
15. S. Henness, C.K. Johnson, Q. Ge, C.L. Armour, J.M. Hughes, and A.J. Ammit IL-17A augments TNF-alpha-induced IL-6 expression in airway smooth muscle by enhancing mRNA stability J Allergy Clin Immunol 114 2004 958 964
16. C. Karagiannidis, M. Akdis, P. Holopainen, N.J. Woolley, G. Hense, and B. Ruckert Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma J Allergy Clin Immunol 114 2004 1425 1433
17. A.J. Leslie, K.J. Pfafferott, P. Chetty, R. Draenert, M.M. Addo, and M. Feeney HIV evolution: CTL escape mutation and reversion after transmission Nat Med 10 2004 282 289
18. M.T. Dorak, J. Tang, A. Penman-Aguilar, A.O. Westfall, I. Zulu, and E.S. Lobashevsky Transmission of HIV-1 and HLA-B allele-sharing within serodiscordant heterosexual Zambian couples Lancet 363 2004 2137 2139
19. R. Draenert, S. Le Gall, K.J. Pfafferott, A.J. Leslie, P. Chetty, and C. Brander Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection J Exp Med 199 2004 905 915
20. R. Winchester, J. Pitt, M. Charurat, L.S. Magder, H.H. Goring, A. Landay, and J.S. Read Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanisms J Acquir Immune Defic Syndr 36 2004 659 670
21. S. Moir, A. Malaspina, O.K. Pickeral, E.T. Donoghue, J. Vasquez, and N.J. Miller Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily J Exp Med 200 2004 587 592
22. M. Kulka, L. Alexopoulou, R.A. Flavell, and D.D. Metcalfe Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3 J Allergy Clin Immunol 114 2004 174 178
23. J.S. Marshall, and D.M. Jawdat Mast cells in innate immunity J Allergy Clin Immunol 114 2004 21 27
24. T.H. Flo, K.D. Smith, S. Sato, D.J. Rodriguez, M.A. Holmes, and R.K. Strong Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron Nature 432 2004 917 921
25. S. Rakoff-Nahoum, J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis Cell 118 2004 229 241
26. A.E. Gelman, J. Zhang, Y. Choi, and L.A. Turka Toll-like receptor ligands directly promote activated CD4+ T cell survival J Immunol 172 2004 6065 6073
27. J.P. Depta, F. Altznauer, K. Gamerdinger, C. Burkhart, H.U. Weltzien, and W.J. Pichler Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity J Allergy Clin Immunol 113 2004 519 527
28. A. Nassif, A. Bensussan, L. Boumsell, A. Deniaud, H. Moslehi, and P. Wolkenstein Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells J Allergy Clin Immunol 114 2004 1209 1212
29. B. Ng, F. Yang, D.P. Huston, Y. Yan, Y. Yang, Z. Xiong, and L.E. Peterson Increased noncanonical splicing of autoantigen transcripts provides the structural basis for expression of untolerized epitopes J Allergy Clin Immunol 114 2004 1463 1470
30. T. Nakajima, M. Iikura, Y. Okayama, K. Matsumoto, C. Uchiyama, and T. Shirakawa Identification of granulocyte subtype-selective receptors and ion channels by using a high-density oligonucleotide probe array J Allergy Clin Immunol 113 2004 528 535
31. S. Hoffjan, I. Ostrovnaja, D. Nicolae, D.L. Newman, R. Nicolae, and R. Gangnon Genetic variation in immunoregulatory pathways and atopic phenotypes in infancy J Allergy Clin Immunol 113 2004 511 518
32. N.A. Hanania, M. Sockrider, M. Castro, J.T. Holbrook, J. Tonascia, and R. Wise Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy J Allergy Clin Immunol 113 2004 717 724
33. L. Notarangelo, J.L. Casanova, A. Fischer, J. Puck, F. Rosen, and R. Seger Primary immunodeficiency diseases: an update J Allergy Clin Immunol 114 2004 677 687
34. C. Cunningham-Rundles, P. Sidi, L. Estrella, and J. Doucette Identifying undiagnosed primary immunodeficiency diseases in minority subjects by using computer sorting of diagnosis codes J Allergy Clin Immunol 113 2004 747 755
35. E. Holzelova, C. Vonarbourg, M.C. Stolzenberg, P.D. Arkwright, F. Selz, and A.M. Prieur Autoimmune lymphoproliferative syndrome with somatic Fas mutations N Engl J Med 351 2004 1409 1418
36. J. Chinen, and J.M. Puck Successes and risks of gene therapy in primary immunodeficiencies J Allergy Clin Immunol 113 2004 595 603
37. M. Cavazzana-Calvo, C. Lagresle, S. Hacein-Bey-Abina, and A. Fischer Gene therapy for severe combined immunodeficiency Annu Rev Med 56 2005 585 602
38. H.B. Gaspar, K.L. Parsley, S. Howe, D. King, K.C. Gilmour, and J. Sinclair Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector Lancet 364 2004 2181 2187
39. A. Gardulf, U. Nicolay, D. Math, O. Asensio, E. Bernatowska, and A. Bock Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home J Allergy Clin Immunol 114 2004 936 942
40. J. Chinen, and W.T. Shearer Subcutaneous immunoglobulins: alternative for the hypogammaglobulinemic patient? J Allergy Clin Immunol 114 2004 934 935
41. C.A. Bates, M.C. Ellison, D.A. Lynch, C.D. Cool, K.K. Brown, and J.M. Routes Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency J Allergy Clin Immunol 114 2004 415 416
42. U. Salzer, A. Maul-Pavicic, C. Cunningham-Rundles, S. Urschel, B.H. Belohradsky, and J. Litzman ICOS deficiency in patients with common variable immunodeficiency Clin Immunol 113 2004 234 240
43. K.E. Sullivan The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome Curr Opin Allergy Clin Immunol 4 2004 505 512
44. E.H. Moylett, A.N. Wasan, L.M. Noroski, and W.T. Shearer Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity Clin Immunol 112 2004 106 124
45. M.L. Markert, M.J. Alexieff, J. Li, M. Sarzotti, D.A. Ozaki, and B.H. Devlin Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases J Allergy Clin Immunol 113 2004 734 741
46. A. Etzioni, and H.D. Ochs The Hyper IgM syndrome - an evolving story Pediatr Res 56 2004 519 525
47. Z. Luo, D. Ronai, and M.D. Scharff The role of activation-induced cytidine deaminase in antibody diversification, immunodeficiency, and B-cell malignancies J Allergy Clin Immunol 114 2004 726 735
48. J.S. Orange, A. Jain, Z.K. Ballas, L.C. Schneider, R.S. Geha, and F.A. Bonilla The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation J Allergy Clin Immunol 113 2004 725 733
49. J.S. Orange, O. Levy, S.R. Brodeur, K. Krzewski, R.M. Roy, and J.E. Niemela Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia J Allergy Clin Immunol 114 2004 650 656
50. T. Niehues, J. Reichenbach, J. Neubert, S. Gudowius, A. Puel, and G. Horneff Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia J Allergy Clin Immunol 114 2004 1456 1462
51. L. Wen, J.P. Atkinson, and P.C. Giclas Clinical and laboratory evaluation of complement deficiency J Allergy Clin Immunol 113 2004 585 593
52. M.M. Frank Hereditary angioedema: a half century of progress J Allergy Clin Immunol 114 2004 626 628
53. T. Bowen, M. Cicardi, H. Farkas, K. Bork, W. Kreuz, and L. Zingale Canadian 2003 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema J Allergy Clin Immunol 114 2004 629 637
54. N. Tangsinmankong, W. Kamchaisatian, J. Lujan-Zilbermann, C.L. Brown, J.W. Sleasman, and P.J. Emmanuel Varicella zoster as a manifestation of immune restoration disease in HIV-infected children J Allergy Clin Immunol 113 2004 742 763